Again, BJ was shown to alleviate hepatic steatosis in an animal model of diet-induced metabolic syndrome and cardiovascular risk via the reduction in IL-6 and TNF-α plasma levels and ROS generation [77]. This evidence concerns the gene IL6 and metabolic syndrome.